Thomas J. Gunderson's Insider Trades & SAST Disclosures
Thomas J. Gunderson's most recent trade in Merit Medical Systems, Inc. was a trade of 2,152 Common Stock, No Par Value done . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas J. Gunderson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merit Medical Systems, Inc. | Thomas J. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 2,152 | 36,034 (0%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Thomas J. Gunderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.50 per share. | 28 Feb 2025 | 25,000 | 46,688 (0%) | 0% | 50.5 | 1,262,500 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Thomas J. Gunderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 25,000 | 0 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems, Inc. | Thomas J. Gunderson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.95 per share. | 28 Feb 2025 | 12,806 | 33,882 (0%) | 0% | 100.0 | 1,279,960 | Common Stock, No Par Value |
| Transmedics Group Inc | Thomas J. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 1,154 | 1,154 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Thomas J. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 732 | 1,925 (0%) | 0% | 0 | Common Stock | |
| Merit Medical Systems, Inc. | Thomas J. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 2,431 | 21,688 (0%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Thomas J. Gunderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.40 per share. | 04 Mar 2024 | 25,000 | 37,414 (0%) | 0% | 34.4 | 860,000 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Thomas J. Gunderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 25,000 | 0 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems, Inc. | Thomas J. Gunderson | Director | Sale of securities on an exchange or to another person at price $ 76.03 per share. | 04 Mar 2024 | 18,157 | 19,257 (0%) | 0% | 76.0 | 1,380,513 | Common Stock, No Par Value |
| Transmedics Group Inc | Thomas J. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 1,916 | 1,916 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Thomas J. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 1,193 | 1,193 (0%) | 0% | 0 | Common Stock | |
| Merit Medical Systems, Inc. | Thomas J. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 2,262 | 12,414 (0%) | 0% | 0 | Common Stock, No Par Value | |
| Transmedics Group Inc | Thomas J. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Merit Medical Systems, Inc. | Thomas J. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 3,050 | 10,152 (0%) | 0% | 0 | Common Stock, No Par Value |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges